Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A pilot study of regenerative therapy using controlled release of recombinant human fibroblast growth factor for patients with pre-collapse osteonecrosis of the femoral head.
Kuroda Y, Asada R, So K, Yonezawa A, Nankaku M, Mukai K, Ito-Ihara T, Tada H, Yamamoto M, Murayama T, Morita S, Tabata Y, Yokode M, Shimizu A, Matsuda S, Akiyama H. Kuroda Y, et al. Among authors: asada r. Int Orthop. 2016 Aug;40(8):1747-1754. doi: 10.1007/s00264-015-3083-1. Epub 2015 Dec 29. Int Orthop. 2016. PMID: 26715504 Free article.
Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial.
Kuroda Y, Tanaka T, Miyagawa T, Hamada H, Abe H, Ito-Ihara T, Asada R, Fujimoto Y, Takahashi D, Tetsunaga T, Kaneuji A, Takagi M, Inaba Y, Morita S, Sugano N, Tanaka S, Matsuda S, Akiyama H; TRION trial collaborators:. Kuroda Y, et al. Among authors: asada r. Regen Med. 2021 Jun;16(6):535-548. doi: 10.2217/rme-2021-0049. Epub 2021 Jun 2. Regen Med. 2021. PMID: 34075804 Free article. Clinical Trial.
Femoral head collapse rate among Japanese patients with pre-collapse osteonecrosis of the femoral head.
Asada R, Abe H, Hamada H, Fujimoto Y, Choe H, Takahashi D, Ueda S, Kuroda Y, Miyagawa T, Yamada K, Tanaka T, Ito J, Morita S, Takagi M, Tetsunaga T, Kaneuji A, Inaba Y, Tanaka S, Matsuda S, Sugano N, Akiyama H. Asada R, et al. J Int Med Res. 2021 Jun;49(6):3000605211023336. doi: 10.1177/03000605211023336. J Int Med Res. 2021. PMID: 34187212 Free PMC article.
Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts.
Sumi E, Nomura T, Asada R, Uozumi R, Tada H, Amino Y, Sawada T, Yonezawa A, Hagiwara M, Kabashima K. Sumi E, et al. Among authors: asada r. Clin Drug Investig. 2019 Jan;39(1):55-61. doi: 10.1007/s40261-018-0712-7. Clin Drug Investig. 2019. PMID: 30284700 Free PMC article. Clinical Trial.
170 results